This is a preview of subscription content, log in via an institution to check access.
Reference
Hart A, et al. Observational data from the adalimumab post-marketing PYRAMID registry of patients with Crohn's disease who became pregnant: A post hoc analysis. United European Gastroenterology Journal 10: 485-495, No. 5, Jun 2022. Available from: URL: http://doi.org/10.1002/ueg2.12236
Rights and permissions
About this article
Cite this article
Adalimumab. Reactions Weekly 1916, 19 (2022). https://doi.org/10.1007/s40278-022-19478-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-19478-x